MIRA Pharmaceuticals, Inc. (MIRA)

NASDAQ: MIRA · Real-Time Price · USD

0.775528

-0.0126 (-1.60%)

Aug 25, 2026, 3:25 PM EDT - Market open

MIRA Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	33	63	19	16	-	-
Market Cap Growth	19.51%	234.93%	21.65%	-	-	-
Enterprise Value	24	56	15	10	-	-
Last Close Price	0.79	1.51	1.14	1.05	-	-

Price Ratios

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
PB Ratio	4.06	6.09	8.58	3.55	-	-
P/TBV Ratio	4.12	6.09	8.58	3.55	-	-

Financial Efficiency

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Debt / Equity Ratio	-	0.06	-	0.00	-0.82	0.13
Net Debt / Equity Ratio	-0.99	-1.01	-1.29	-1.05	-0.23	-1.11
Quick Ratio	198.75	15.71	3.92	8.27	0.26	2.57
Current Ratio	200.08	15.75	3.99	8.71	0.36	2.66
Return on Equity (ROE)	-217.12%	-165.87%	-238.90%	-634.30%	-847.77%	-198.47%
Return on Assets (ROA)	-129.55%	-93.58%	-127.59%	-184.05%	-209.10%	-79.65%
Return on Capital Employed (ROCE)	-115.20%	-101.00%	-364.50%	-194.90%	1376.60%	-95.20%

Yields

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug '26 Aug 25, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Earnings Yield	-92.31%	-16.51%	-41.59%	-77.21%	-	-
Buyback Yield / Dilution	-115.16%	-53.42%	-10.91%	20.73%	-38.60%	-

SEC Filings: 10-K · 10-Q